UBS AM
TRNS icon

UBS AM’s Transcat TRNS Stock Holding History

UBS AM’s Portfolio TRNS Stock Details TRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
11,772
-271
-2% -$22.1K ﹤0.01% 2313
2026
Q1 		$885K Hold
12,043
– – ﹤0.01% 2383
2025
Q4 		$683K Buy
12,043
+4
+0% +$249 ﹤0.01% 2255
2025
Q3 		$881K Sell
12,039
-12,713
-51% -$1.02M ﹤0.01% 2046
2025
Q2 		$2.13M Buy
24,752
+4,498
+22% +$368K ﹤0.01% 2108
2025
Q1 		$1.51M Buy
20,254
+3,225
+19% +$270K ﹤0.01% 2134
2024
Q4 		$1.8M Buy
17,029
+3,307
+24% +$367K ﹤0.01% 2105
2024
Q3 		$1.66M Sell
13,722
-1,719
-11% -$214K ﹤0.01% 2144
2024
Q2 		$1.85M Buy
15,441
+9,449
+158% +$1.12M ﹤0.01% 2039
2024
Q1 		$668K Hold
5,992
– – ﹤0.01% 2193
2023
Q4 		$655K Hold
5,992
– – ﹤0.01% 2226
2023
Q3 		$587K Buy
5,992
+1,092
+22% +$104K ﹤0.01% 2229
2023
Q2 		$438K Hold
4,900
– – ﹤0.01% 2373
2023
Q1 		$438K Buy
4,900
+700
+17% +$59.6K ﹤0.01% 2373
2022
Q4 		$298K Buy
+4,200
New +$320K ﹤0.01% 2331

Other funds holding TRNS

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM's TRNS Position: Q2 2026 in Review

UBS AM reduced its Transcat (TRNS) stake by 2.3% in Q2 2026, selling an estimated $22.1K and leaving 11,772 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

UBS AM first reported a position in TRNS in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.13M in Q2 2025. 173 funds tracked by Wall St. Rank hold TRNS as of Q2 2026.

  • UBS AM held 11,772 shares of Transcat worth $1.09M as of Q2 2026.
  • UBS AM sold 271 Transcat shares in Q2 2026, an estimated $22.1K.
  • Transcat made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2313 holding.
  • UBS AM first reported a position in Transcat in Q4 2022 and has held it in 15 quarters since.
  • UBS AM's Transcat position peaked at $2.13M in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Transcat as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.